Serum P-glycoprotein level: a potential biomarker of DMARD failure in patients with rheumatoid arthritis
2018
Objectives
To evaluate the utility of elevated serum P-glycoprotein (P-gp) as a risk marker of therapeutic response failure in rheumatoid arthritis (RA) patients treated with disease-modifying antirheumatic drugs (DMARDs).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
31
References
3
Citations
NaN
KQI